Resistance Training and Protein Supplementation for Prostate Cancer Survivors

Completed · Not applicable

Conditions studied: Prostate Cancer

In brief

This randomized pilot clinical trial studies resistance training and protein supplementation in increasing lean body mass in patients with prostate cancer receiving androgen deprivation therapy. Resistance training and protein supplementation may help improve quality of life in patients with prostate cancer receiving androgen deprivation therapy.

Key facts

Study ID

NCT01909440

Run by

University of Southern California

People needed

43

Starts

2013-07-08

Expected to finish

2018-08-07

Last updated by the study team

2019-06-19

Who can join

Age: 50 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with prostate cancer
• Treatment with androgen deprivation therapy (ADT) (gonadotropin-releasing hormone [GnRH] agonist/antagonist with or without anti-androgen) for prostate cancer
• Receiving ADT for a minimum of 12 weeks before enrollment into the study
• Planned ADT for the duration of the 12-week study period
• Asymptomatic, or minimally symptomatic from prostate cancer or prostate cancer related therapies
• No opioid-requiring cancer related pain
• Any therapy related genitourinary or gastrointestinal symptoms should be considered as mild (Common Terminology Criteria for Adverse Events [CTCAE] grade 1 or 2) and not interfering with activities of daily living
• Permission from treating/study physician to participate in RT

You may not qualify if…

• No concurrent use of chemotherapy or radiotherapy (radiotherapy should be completed at least 4 weeks from study entry)
• History of allergic reactions to whey protein
• Milk protein intolerance/allergies (lactose intolerance is acceptable)
• Subjects currently using N-acetylcysteine, alpha-lipoic acid supplements, or dry whey protein supplements
• Recovered from major surgery within the last 6 months
• Acute coronary (e.g. myocardial infarction) or vascular event within the last year as well as uncontrolled coronary heart disease (e.g. progressive angina)
• Stroke within the past 2 years
• Neurologic and/or orthopedic limitations that preclude the participation in the training program (e.g. bone metastases that may pose a high risk of pathologic fracture)
• Subjects currently participating in a RT program

Where it is running

• USC Norris Comprehensive Cancer Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.